Zai Lab (ZLAB) Partner Novocure (NVCR) Announces METIS Phase 3 Clinical Trial Met Primary Endpoint
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Nasdaq hits near three-month low as Amazon, Intel deepen AI capex concerns
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil set for fourth monthly gain as Hormuz tanker attack highlights supply risks
| (NASDAQ: NVCR) | Delayed: 12.90 -0.21 (1.6%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.11 | 52 Week High | $28.95 | |||
| Open | $12.81 | 52 Week Low | $5.95 | |||
| Day High | $13.00 | P/E | N/A | |||
| Day Low | $12.52 | EPS | $0.00 | |||
| Volume | 262,738 | |||||
| (NASDAQ: ZLAB) | Delayed: 21.97 -0.39 (1.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $22.36 | 52 Week High | $ | |||
| Open | $22.30 | 52 Week Low | $ | |||
| Day High | $22.33 | P/E | N/A | |||
| Day Low | $21.80 | EPS | $ | |||
| Volume | 104,029 | |||||
